A 62-year-old woman with stage IIIC2 endometrial carcinoma (para-aortic lymph node involvement) is being considered for systemic therapy. She has completed surgery and pelvic radiotherapy. She has a performance status of 0 and normal renal and cardiac function. What is the drug of choice for first-line chemotherapy?